Study of BMS-754807 Combined With Letrozole or BMS-754807 Alone in Patients With Hormone Receptor-Positive Breast Cancer and Resistance to Non-Steroidal Aromatase Inhibitors
Public ClinicalTrials.gov record NCT01225172. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Study of BMS-754807 Combined With Letrozole or BMS-754807 Alone in Hormone Receptor-Positive Breast Cancer Subjects With Acquired Resistance to Non-Steroidal Aromatase Inhibitors
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate oral doses of BMS-754807 in combination with letrozole or BMS-754807 alone are safe and efficacious in locally advanced or metastatic hormone receptor positive breast cancer subjects who have progressed with prior non-steroidal aromatase inhibitor treatment.
Study identification
- NCT ID
- NCT01225172
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 77 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2010 (Actual)
- Primary completion
- Nov 30, 2014 (Actual)
- Completion
- Nov 30, 2014 (Actual)
- Last update posted
- Aug 11, 2020
2010 – 2014
United States locations
- U.S. sites
- 21
- U.S. states
- 12
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Univ Of Al At Birmingham | Birmingham | Alabama | 35294 | — |
| Mayo Clinic Arizona | Scottsdale | Arizona | 85259 | — |
| Sharp Clinical Oncology Research | San Diego | California | 92123 | — |
| Mayo Clinic | Jacksonville | Florida | 32224 | — |
| University Of Chicago Medical Center | Chicago | Illinois | 60637 | — |
| Illinois Cancercare, Pc | Peoria | Illinois | 61615 | — |
| Indiana University Health Goshen Center For Cancer Care | Goshen | Indiana | 46526 | — |
| Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins | Baltimore | Maryland | 21231-1000 | — |
| Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins | Baltimore | Maryland | 21231 | — |
| Oncology Care Associates, P.A. | Wheaton | Maryland | 20902 | — |
| Masonic Cancer Ctr, University Of Minnesota | Minneapolis | Minnesota | 55455 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Unv. Of Nc At Chapel Hill | Chapel Hill | North Carolina | 27599-7305 | — |
| Unv. Of Nc At Chapel Hill | Chapel Hill | North Carolina | 27599 | — |
| Presbyterian Hospital Cancer Research | Charlotte | North Carolina | 28204 | — |
| Duke University Medical Center-Dept Of Medicine | Durham | North Carolina | 27710 | — |
| Ut Md Anderson Can Ctr. | Houston | Texas | 77030-4009 | — |
| Ut Md Anderson Can Ctr. | Houston | Texas | 77030 | — |
| University Of Virginia Health System | Charlottesville | Virginia | 22908 | — |
| University Of Wisconsin | Madison | Wisconsin | 53792-6164 | — |
| University Of Wisconsin | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01225172, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 11, 2020 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01225172 live on ClinicalTrials.gov.